Clinical Research and Evidence While large-scale human trials are still limited, the body of research on BPC-157 peptide paints a compelling picture of its therapeutic potential, especially in conditions that mirror the challenges of chronic Lyme disease
Some patients experience mild injection site soreness or temporary flushing
My mixed Retatrutide solution looks cloudy
If fatigue persists or worsens over time, checking B12 levels, thyroid function, and other nutritional markers is warranted
Since some peptides have contraindications, the consultation ensures you fully understand the risks and benefits before starting therapy
Chemical Instability: Over time, the active ingredients in compounded medications may degrade, leading to unpredictable results